Đang tải…
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...
Những tác giả chính: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Định dạng: | Texto |
Ngôn ngữ: | English |
Được phát hành: |
BMJ Group
2010
|
Những chủ đề: | |
Truy cập trực tuyến: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/ https://www.ncbi.nlm.nih.gov/pubmed/20444750 http://dx.doi.org/10.1136/ard.2009.126532 |